Skip to main content
Fig. 7. | Journal of Experimental & Clinical Cancer Research

Fig. 7.

From: Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells

Fig. 7.

Schematic summary of our study. We showed the distinct effects of EGFR inhibitors on epithelial-like and mesenchymal-like ESCC cells. In epithelial-like ESCC cells, suppression of EGFR signaling due to EGFR inhibitors resulted in the promotion of squamous cell differentiation and cell growth inhibition; conversely, activation of EGFR phosphorylation due to rEGF suppressed squamous cell differentiation. In contrast, neither EGFR inhibitors nor rEGF affected EGFR phosphorylation in mesenchymal-like ESCC cells, and thereby mesenchymal-like ESCC cells are considered to be resistant to EGFR inhibitors.

Back to article page